Thrombosis News and Research

Latest Thrombosis News and Research

New cardiovascular drug derived from Dan Shen (Saliva miltiorrhiza)

Through a large number of clinical trials over the past 3 years, researchers from the CAS Shanghai Institute of Materia Medica (SIMM) have developed a new cardiovascular drug with a definite effective component extracted from Dan Shen (Saliva miltiorrhiza), a medicinal herb widely used in China.

21 Jun 2005

Thalidomide may be a potent anti-cancer treatment

When people hear "thalidomide," many think "birth defects," however, evidence has come to light that this once-banned drug can be used as a potent anti-cancer treatment.

20 Jun 2005

Special stockings reduce DVT risk on long flights

According to new research, passengers on long flights can lessen the risk of deep vein thrombosis (DVT) by wearing special stockings.

15 Jun 2005

Hypertension, diabetes and obesity are important independent predictors of increased complications for patients undergoing major joint replacement surgery

Using a database of nearly 1 million Americans who underwent major joint replacement surgery, a team led by researchers at Duke University Medical Center have determined those surgical patients with diabetes, hypertension or obesity were significantly more likely to suffer post-operative complications.

1 Jun 2005

Long-haul flights, length of time under anesthesia increase risk of developing blood clots

The prolonged immobility of flight passengers during long-haul air travel increases the risk of developing blood clots, which could prove fatal especially to people whose travel occurs just prior to major surgery, medical researchers report in the current issue of Mayo Clinic Proceedings.

31 May 2005

Specific variants of genes predict bleeding after heart surgery

Duke University Medical Center researchers have found that the presence of specific variants of genes that control clotting and the contractility, or "tone," of blood vessels can double the ability of physicians to predict those heart surgery patients at greatest risk of bleeding after surgery.

4 May 2005

Severely obese children have lipoprotein profiles that signal early risk of cardiovascular disease and the metabolic syndrome

"The message is urgent about the importance of prevention of cardiovascular disease in childhood. Lifestyle modification with appropriate diet and exercise can reduce cardiovascular risk in children," said lead author Daniel L. Preud'Homme, M.D., associate professor of medicine at the Wright State University School of Medicine and director of the lipid clinic at The Children's Medical Center, both in Dayton, Ohio.

1 May 2005

Fiber supplements may lower cardiovascular risk in type 2 diabetics

Fiber supplements lower "bad" low-density lipoprotein (LDL) cholesterol and increase "good" high-density lipoprotein (HDL) cholesterol in people with type 2 diabetes, according to a study presented at the American Heart Association's Sixth Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.

1 May 2005

Levels of anti–clotting proteins influence pregancy outcomes

Recurrent miscarriage, stillbirth, preeclampsia, poor fetal growth, preterm delivery and bleeding in pregnancy are influenced by low levels of the anti–clotting proteins Z and S, Yale School of Medicine researchers report in the March issue of Journal of Thrombosis and Haemostasis.

12 Apr 2005

Chemoembolization, first-line treatment for liver cancer

New research by Jeff Geschwind, M.D., director of interventional radiology and associate professor at Johns Hopkins University School of Medicine, has shown that liver cancer patients, most of whom have inoperable tumours, could benefit from chemoembolization, a nonsurgical treatment option that delivers a high-dose of chemotherapy to the tumour while decreasing blood flow through the arteries feeding the tumour, known as embolization.

4 Apr 2005

Red blood cells lump by mobile phone

Two students of the Gymnasium high school in Spaichingen (Germany) have investigated the influence of using a mobile phone on the red blood cells. With a microscope they made 255 pictures of the blood of 51 testees.

22 Mar 2005

Support for the use of low-dose aspirin therapy in preventing and treating pre-eclampsia

A new study led by Queen’s University researcher Colin Funk provides indirect support for the use of low-dose aspirin therapy in preventing and treating pre-eclampsia – a pregnancy disorder that is often harmful to both mother and fetus.

22 Mar 2005

Discovery of a single mutation responsible for a number of blood disorders

Myeloproliferative disorders form a range of haematological malignant diseases, with three main members: polycythaemia vera, essential thrombocythaemia, and idiopathic myelofi- brosis. The disorders are characterised by overactive production of blood cells and can lead to thrombosis, haemorrhage or acute myeloid leukaemia.

21 Mar 2005

Mountaineering doctors hike medicine to new heights with Xtreme Everest

Doctors working at the edge of extreme are set to climb the world’s tallest mountain to look death in the face – and take its pulse. The medical research team will make the first ever measurements of blood oxygen in the ‘death zone’, at altitudes above 8,000 metres where the human body has struggled - and frequently failed - to survive.

16 Mar 2005

Doctors may in future be able to prevent many cases of deep-vein thrombosis

Doctors may in future be able to prevent many cases of deep-vein thrombosis, commonly referred to as DVT, a disease of the circulation that causes potentially fatal blood clots. It occurs most often in people who have not been able to exercise normally.

9 Mar 2005

Drug eluting stents as effective as vascular brachytherapy in preventing restenosis

After angioplasty is performed to widen clogged arteries, surgeons frequently use tiny wire-mesh tubes called stents to keep blood vessels open. But despite stenting, scar tissue can form to create new blockages -- a process called in-stent restenosis (ISR).

7 Mar 2005

Use of cilostazol, clopidogrel and aspirin results in a significant reduction of thrombotic complications in the prevention of heart attacks

Three drugs, each of which works in a different way, are used in anti-platelet therapy to help prevent restenosis (the reclogging of blood vessels after they have been cleared with percutaneous coronary intervention or PCI) or thrombosis (obstruction of an artery or vein by a blood clot).

7 Mar 2005

Stent trial fails to meet endpoints

Angiotech Pharmaceuticals has announced that results from the REALITY Trial, a head-to-head trial sponsored by Cordis Corporation, comparing the JNJ CYPHER® stent and the TAXUS® stent, were presented at the American College of Cardiology Annual Scientific Session. The trial failed to meet its primary endpoint.

7 Mar 2005

Clot-dissolving drugs such as tPA may help detect potentially deadly leg clots

A possible diagnostic use for clot-dissolving drugs such as tPA has been found by Medical College of Georgia researchers working to improve a test that identifies potentially deadly blood clots in the legs.

14 Feb 2005

Patients with cancer have a 7-fold increased risk for blood clots in the legs or lungs

Studies that identify patients at highest risk of thrombosis are scarce, according to background information in the article. It is unclear what risks are for various types and stages of cancer.

9 Feb 2005